AF after mitral valve replacement is an accepted indication for anticoagulation, but the data supporting anticoagulation in patients after mitral valve repair who convert to sinus rhythm are sparse.

Conclusion Warfarin dosages required to maintain a goal INR of 2.0–3.0 were relatively stable in the four weeks before and after procedures to convert atrial fibrillation or flutter to sinus rhythm.